DZ Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,071
Closed -$1.41M 1100
2026
Q1
$1.41M Buy
+25,071
New +$1.63M ﹤0.01% 676
2021
Q2
Sell
-1,992
Closed -$221K 962
2021
Q1
$221K Hold
1,992
﹤0.01% 778
2020
Q4
$237K Buy
+1,992
New +$214K ﹤0.01% 745
2018
Q4
Sell
-11,663
Closed -$1.34M 774
2018
Q3
$1.34M Hold
11,663
﹤0.01% 496
2018
Q2
$1.04M Buy
+11,663
New +$985K ﹤0.01% 562

Other funds holding HAE

DZ Bank's HAE Position: Q2 2026 in Review

DZ Bank sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 25,071 shares — an estimated $1.41M sold.

DZ Bank first reported a position in HAE in Q2 2018 and held it in 5 quarters. The position peaked at $1.41M in Q1 2026. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • DZ Bank reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • DZ Bank sold 25,071 Haemonetics shares in Q2 2026, an estimated $1.41M.
  • DZ Bank first reported a position in Haemonetics in Q2 2018 and held it in 5 quarters.
  • DZ Bank's Haemonetics position peaked at $1.41M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.